Our new partner company develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for neurological disorders, oncology and respiratory diseases.
The company’s products are marketed in over a hundred countries, and the Group’s own human pharmaceuticals sales organization covers all key European markets and a few Southeast Asian countries. In other markets the company’s products are sold by several collaboration partners. All the company’s manufacturing plants and most of its R&D operations are in Europe.
The following PV business processes will be enhanced as a result of implementing RxLogix Safety platform: